Analogic Corp. (ALOG, Financial) filed Annual Report for the period ended 2009-07-31.
Analogic Corporation conceives designs manufactures and sells standard and customized high-precision data acquisition signal and imaging processing based medical imaging and industrial systems and subsystems. Analogic's principal customers are original equipment manufacturers who incorporate Analogic's state-of-the-art products into systems used in medical industrial and scientific applications. Analogic Corp. has a market cap of $464.2 million; its shares were traded at around $37.01 with a P/E ratio of 69.7 and P/S ratio of 1.2. The dividend yield of Analogic Corp. stocks is 1.1%. Analogic Corp. had an annual average earning growth of 61.5% over the past 5 years.
Our R&D costs included in engineering cost of sales amounted to $21,398 in fiscal year 2009, $14,480 in fiscal year 2008, and $15,736 in fiscal year 2007. Our R&D costs included in operating expenses amounted to $45,276 in fiscal year 2009, $48,947 in fiscal year 2008, and $46,955 in fiscal year 2007. We intend to continue our emphasis on new product development. As of July 31, 2009, we employed approximately 410 employees engaged in R&D activities, including electrical engineers, software engineers, physicists, mathematicians, and technicians. These individuals, in conjunction with our sales and marketing staff, also devote a portion of their time to assisting customers in utilizing our products, developing new uses for these products, and anticipating customer requirements for new products.
We capitalized $1,672 and $2,719 in fiscal year 2009 and fiscal year 2008, respectively, of computer software testing and coding costs incurred after technological feasibility was established. These costs are amortized using a straight-line method over the estimated economic life of the related products, generally three years, and are included in product cost of sales.
Our domestic and foreign revenues were $309,885, or 78%, and $86,264, or 22%, respectively, in fiscal year 2009 as compared to $327,181, or 79%, and $86,328, or 21%, respectively, in fiscal year 2008, and $273,746, or 80%, and $67,036, or 20%, respectively, in fiscal year 2007.
Read the The complete Report
Analogic Corporation conceives designs manufactures and sells standard and customized high-precision data acquisition signal and imaging processing based medical imaging and industrial systems and subsystems. Analogic's principal customers are original equipment manufacturers who incorporate Analogic's state-of-the-art products into systems used in medical industrial and scientific applications. Analogic Corp. has a market cap of $464.2 million; its shares were traded at around $37.01 with a P/E ratio of 69.7 and P/S ratio of 1.2. The dividend yield of Analogic Corp. stocks is 1.1%. Analogic Corp. had an annual average earning growth of 61.5% over the past 5 years.
Highlight of Business Operations:
Our OEM business involves large customers whose placement of orders can vary based on the timing of large orders. In addition, we have agreed to maintain consignment inventories for some of our OEM customers, the transition to which has reduced our backlog during the past year. Our backlog, which consists of cancellable and non-cancellable orders that are expected to ship primarily within the next 12 months, was $78,434 at July 31, 2009 as compared to $137,457 at July 31, 2008. The backlog decrease of $59,023 was due primarily to decreases in the backlog of our Medical Imaging Products, Security Technology Products, and Digital Radiography Products segments of $31,324, $18,830, and $7,570, respectively. The backlog decrease in Medical Imaging Products was due primarily to the global economic conditions, timing of customer orders, and an increase in the number of customers transitioning to a consignment inventory system. The decrease in Security Technology Products was due primarily to a product transition and the timing of purchase orders. The decrease in Digital Radiography Products was due primarily to a slight delay in an annual order from a key OEM customer.Our R&D costs included in engineering cost of sales amounted to $21,398 in fiscal year 2009, $14,480 in fiscal year 2008, and $15,736 in fiscal year 2007. Our R&D costs included in operating expenses amounted to $45,276 in fiscal year 2009, $48,947 in fiscal year 2008, and $46,955 in fiscal year 2007. We intend to continue our emphasis on new product development. As of July 31, 2009, we employed approximately 410 employees engaged in R&D activities, including electrical engineers, software engineers, physicists, mathematicians, and technicians. These individuals, in conjunction with our sales and marketing staff, also devote a portion of their time to assisting customers in utilizing our products, developing new uses for these products, and anticipating customer requirements for new products.
We capitalized $1,672 and $2,719 in fiscal year 2009 and fiscal year 2008, respectively, of computer software testing and coding costs incurred after technological feasibility was established. These costs are amortized using a straight-line method over the estimated economic life of the related products, generally three years, and are included in product cost of sales.
Our domestic and foreign revenues were $309,885, or 78%, and $86,264, or 22%, respectively, in fiscal year 2009 as compared to $327,181, or 79%, and $86,328, or 21%, respectively, in fiscal year 2008, and $273,746, or 80%, and $67,036, or 20%, respectively, in fiscal year 2007.
Read the The complete Report
